Anti-Glutamate receptor 3/GluA3 antibody [EP813Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(22 Publications)
Rabbit Recombinant Monoclonal Glutamate receptor 3/GluA3 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 22 publications.
View Alternative Names
GluA3, GLUR3, GLURC, GRIA3, Glutamate receptor 3, GluR-3, AMPA-selective glutamate receptor 3, GluR-C, GluR-K3
- WB
Lab
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/1000 dilution
All lanes:
Human hippocampus lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 101 kDa
false
- WB
Unknown
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
All lanes:
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/5000 dilution
All lanes:
human brain lysate at 10 µg
Predicted band size: 101 kDa
Observed band size: 95 kDa
false
- WB
Lab
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/2000 dilution
Lane 1:
Mouse hippocampus lysates at 20 µg
Lane 2:
Rat brain lysates at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution
Predicted band size: 101 kDa
Observed band size: 100 kDa
false
- WB
Lab
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
In Western blot, Anti-Myc tag antibody [9E10] - Loading Control (ab32) staining at 1/10000 dilution.
This antibody does not cross-react with Human GRIA1,GRIA2 and GRIA4.
Exposure time : ab40845 : 40s, ab32 : 80s.
All lanes:
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (ab40845) at 1/1000 dilution
Lane 1:
293T transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate at 20 µg
Lane 2:
293T transfected with Human fragment GRIA2 expression vector containing a c-term myc-His-tag®, whole cell lysate at 20 µg
Lane 3:
293T transfected with Human full length GRIA3 expression vector containing a n-term myc-His-tag®, whole cell lysate at 20 µg
Lane 4:
293T transfected with human full length GRIA4 expression vector containing a c-term myc-His-tag®, whole cell lysate at 20 µg
Lane 5:
Recombinant Human full length GRIA1 Protein containing a C-Myc/DDK tag at 100 ng
Secondary
Lanes 1 - 5:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lanes 1 - 5:
Goat anti-mouse IgG (H+L), Peroxidase conjugated at 1/10000 dilution
Observed band size: 100 kDa
false
- WB
CiteAb
Western blot - Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] (AB40845)
Glutamate receptor 3/GluA3 western blot using anti-Glutamate receptor 3/GluA3 antibody [EP813Y] ab40845. Publication image and figure legend from Adotevi, N. K. & Leitch, B., 2018, Front Mol Neurosci, PubMed 29311821.
ab40845 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab40845 please see the product overview.
Relative synaptic expression of GluA1–4 in the somatosensory cortex. (A–D) Representative immunoblots showing extrasynaptic and synaptic AMPAR subunit expression; (A) GluA1, (B) GluA2, (C) GluA3 and (D) GluA4, with the loading markers PSD95 and Pan-cadherin. (E) Scatter-plot with bar graphs showing a significant decrease in AMPAR GluA1 (0.79 ± 0.07, n = 6, p < 0.05), GluA2 (0.77 ± 0.08, n = 5, p < 0.05), GluA3 (0.77 ± 0.06, n = 7, p < 0.05), GluA4 (0.66 ± 0.02, n = 5, p < 0.01) expression in stargazer (E) synaptic fractions relative to NE control littermates after normalization against Pan-cadherin. Symbols '*' indicate p value significant digits (*p < 0.05, ***p < 0.005).
false
Related conjugates and formulations (1)
-
Anti-Glutamate receptor 3/GluA3 antibody [EP813Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GluA3 operates as a subunit of AMPA receptors forming tetrameric complexes that facilitate synaptic signal transmission. These channels permit the influx of sodium and to a lesser extent calcium ions when activated by the neurotransmitter glutamate. The interaction of GluA3 with auxiliary proteins like transmembrane AMPA receptor regulatory proteins (TARPs) can modulate its function and trafficking. As an essential component of synaptic transmission GluA3 influences synaptic strength and is involved in various neuronal activities.
Pathways
GluA3 plays an important role in synaptic plasticity and long-term potentiation (LTP). Two important pathways associated with GluA3 are the mitogen-activated protein kinase (MAPK) pathway and the calcium/calmodulin-dependent protein kinase II (CaMKII) pathway. The regulation of these pathways through GluA3 modulation affects synaptic efficacy and memory formation. GluA3 interacts with proteins like PSD-95 which influences receptor assembly and synapse structure integrating into broader signaling networks that govern cellular responses and adaptations.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in molecular neuroscience 18:1635852 PubMed40771360
2025
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 11:e15673 PubMed37078449
2023
Applications
Unspecified application
Species
Unspecified reactive species
The European journal of neuroscience 55:18-31 PubMed34902209
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and cellular biochemistry 477:191-203 PubMed34652536
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 26:773-786 PubMed34729247
2021
Applications
Unspecified application
Species
Unspecified reactive species
The European journal of neuroscience 54:6237-6255 PubMed34390052
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neuroendocrinology 112:493-509 PubMed34348318
2021
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 118: PubMed33593893
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 9:e015487 PubMed32306814
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 129:3864-3876 PubMed31424425
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com